Cargando…
Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment
The success of anticancer treatments relies on a long-term response which can be mediated by the immune system. Thus, the concept of immunogenic cell death (ICD) describes the capacity of dying cancer cells, under chemotherapy or physical stress, to express or release danger-associated molecular pat...
Autores principales: | Roussot, Nicolas, Ghiringhelli, François, Rébé, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688834/ https://www.ncbi.nlm.nih.gov/pubmed/36429101 http://dx.doi.org/10.3390/cells11223672 |
Ejemplares similares
-
STAT3, a Master Regulator of Anti-Tumor Immune Response
por: Rébé, Cédric, et al.
Publicado: (2019) -
Interleukin-1β and Cancer
por: Rébé, Cédric, et al.
Publicado: (2020) -
STAT3 activation: A key factor in tumor immunoescape
por: Rébé, Cédric, et al.
Publicado: (2013) -
Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
por: Bugaut, Hélène, et al.
Publicado: (2013) -
Induction of pyroptosis in colon cancer cells by LXRβ
por: Rébé, Cédric, et al.
Publicado: (2015)